Print

Q Therapeutics, Inc. at Johns Hopkins to Study Use of Neural Glial Cells in Treatment of Myelin Disorders  
6/1/2010 2:53:41 PM

SALT LAKE CITY--(BUSINESS WIRE)--Q Therapeutics, Inc. announced today that Piotr Walczak, M.D., of Johns Hopkins University has received notification of a $1,000,000 grant to be awarded by the Maryland Stem Cell Research Fund (MSCRF) which will enable further study of Q’s human neural glial cell product Q-Cells® in preclinical models of demyelinating disease. Dr. Walczak, Principal Investigator, is an Assistant Professor in the Department of Radiology and Radiological Science and a faculty member of the Cellular Imaging Section (CIS) in the Institute for Cell Engineering (ICE) at Johns Hopkins University School of Medicine.
//-->